Close Menu

NEW YORK (360Dx) – The US Preventive Services Task Force said today that men aged 55 to 59 should decide with their clinicians whether to pursue prostate specific antigen-based cancer screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.